Rajdeep Das, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
DepartmentRadiation Oncology
Address1450 Third St
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    UCSF2017Invited speaker - Prostate Cancer Program Research Workshop: A Multi-Dimensional View of Disparities
    UCSF2017Invited speaker - Radiation Oncology Retreat
    UCSF2017Rapid Fire Presenter - Prostate Cancer Research Program Annual Research Retreat
    The University of Adelaide2016Dean's Commendation for Doctoral Thesis Excellence
    LabArchives, LLC2016ELN Professional Edition - Developmental Grant
    Rashid bin Humaid Award for Culture and Sciences20151st prize for scientific work on extended spectrum beta- lactamase (ESBL)
    The Hospital Research Foundation, Australia2015  - 2015The Hospital Research Foundation 50th Anniversary Award
    Rashid bin Humaid Award for Culture and Sciences20142nd prize for scientific work on methicillin resistance staphylococcus aureus (MRSA)
    Department of Education and Training, Government of Australia and The University of Adelaide2013  - 2016International postgraduate research scholarship (IPRS)
    Gordon Research Conference2015Invited speaker - Gordon Research Symposium: Hormone-Dependent Cancers

    Collapse Overview 
    Collapse Overview
    I am a clinically trained pathologist focused on clinical and translational research aimed at improving outcomes for patients with genitourinary cancers. My research interest include the discovery of prognostic/predictive biomarkers in genitourinary cancers and the development of a comprehensive understanding of underlying molecular mechanisms of cancer metastasis.

    Collapse ORNG Applications 
    Collapse In The News
    Collapse Featured Presentations

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018 Jul 17. PMID: 30033370.
      View in: PubMed
    2. Nguyen EV, Centenera MM, Moldovan M, Das R, Irani S, Vincent AD, Chan H, Horvath LG, Lynn DJ, Daly R, Butler LM. Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants. Mol Cell Proteomics. 2018 Apr 09. PMID: 29632047.
      View in: PubMed
    3. Nguyen EV, Centenera MM, Moldovan M, Das R, Irani S, Vincent AD, Chan H, Horvath LG, Lynn DJ, Daly R, Butler LM.Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants. Molecular & Cellular Proteomics. 2018.
    4. SG Zhao, J Lehrer, SWL Chang, NG Erho, M Sjostrom, RB Den, SJ Freedland, EA Klein, RJ Karnes, EM Schaeffer, M Xu, R Das, AJ Chang, PL Nguyen, E Davicioni, AE Ross, L Fong, DE Spratt, FY Feng.Novel Associations Between the Immune Landscape of Prostate Cancer and Postoperative Radiation Response. International Journal of Radiation Oncology* Biology* Physics. 2017; 99(2).
    5. Paltoglou S, Das R, Townley SL, Hickey TE, Tarulli GA, Coutinho I, Fernandes R, Hanson AR, Denis I, Carroll JS, Dehm SM, Raj GV, Plymate SR, Tilley WD, Selth LA. Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer. Cancer Res. 2017 07 01; 77(13):3417-3430. PMID: 28473532.
      View in: PubMed
    6. Quigley D, Alumkal JJ, Wyatt AW, Kothari V, Foye A, Lloyd P, Aggarwal R, Kim W, Lu E, Schwartzman J, Beja K, Annala M, Das R, Diolaiti M, Pritchard C, Thomas G, Tomlins S, Knudsen K, Lord CJ, Ryan C, Youngren J, Beer TM, Ashworth A, Small EJ, Feng FY. Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors. Cancer Discov. 2017 09; 7(9):999-1005. PMID: 28450426.
      View in: PubMed
    7. Tse BWC, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman ML, McPherson SJ, Roshan-Moniri M, Butler MS, Caradec J, Gregory-Evans CY, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer EM, Jenkins RB, Ross AE, Karnes RJ, Den RB, Fazli L, Gregory PA, Gleave ME, Williams ED, Rennie PS, Buttyan R, Gunter JH, Selth LA, Russell PJ, Nelson CC, Hollier BG. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene. 2017 Jun 15; 36(24):3417-3427. PMID: 28092670.
      View in: PubMed
    8. Das R, Gregory PA, Fernandes RC, Denis I, Wang Q, Townley SL, Zhao SG, Hanson AR, Pickering MA, Armstrong HK, Lokman NA, Ebrahimie E, Davicioni E, Jenkins RB, Karnes RJ, Ross AE, Den RB, Klein EA, Chi KN, Ramshaw HS, Williams ED, Zoubeidi A, Goodall GJ, Feng FY, Butler LM, Tilley WD, Selth LA. MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2. Cancer Res. 2017 02 15; 77(4):1021-1034. PMID: 28011622.
      View in: PubMed
    9. Armstrong HK, Koay YC, Irani S, Das R, Nassar ZD. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response. Prostate. 2016 Dec; 76(16):1546-1559. PMID: 27526951.
      View in: PubMed
    10. Selth LA, Das R, Townley SL, Coutinho I, Hanson AR, Centenera MM, Stylianou N, Sweeney K, Soekmadji C, Jovanovic L, Nelson CC, Zoubeidi A, Butler LM, Goodall GJ, Hollier BG, Gregory PA, Tilley WD. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer. Oncogene. 2017 Jan 05; 36(1):24-34. PMID: 27270433.
      View in: PubMed
    11. Das R, Gregory PA, Hollier BG, Tilley WD, Selth LA. Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends Mol Med. 2014 Nov; 20(11):643-51. PMID: 25262538.
      View in: PubMed